SCHEMBL27668336

SCHEMBL27668336

CC(C)(N)CCN1c2ccccc2CCC1C=O

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MTNR1A P48039 10/20 0.39
▸ CHRM2 P08172 2/20 0.38
▸ CHRM4 P08173 2/20 0.38
▸ CHRM1 P11229 2/20 0.38
▸ CHRM3 P20309 1/20 0.38
▸ DRD4 P21917 2/20 0.36
▸ DRD2 P14416 1/20 0.36
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ POLB P06746 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ TSHR P16473 1/20 0.33
▸ MTNR1B P49286 1/20 0.33
▸ USP2 O75604 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ CDK4 P11802 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ CCND1 P24385 1/20 0.33
▸ SRD5A1 P18405 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28229934 0.82 MTNR1A (0.55) MTNR1ACHRM2CHRM4CHRM1CHRM3
SCHEMBL27570842 0.79 MTNR1A (0.40) MTNR1ACHRM2CHRM4CHRM1CHRM3
SCHEMBL27585383 0.77 MTNR1A (0.44) MTNR1ACHRM2CHRM4CHRM1CHRM3
SCHEMBL27807046 0.76 CHRM2 (0.44) MTNR1ACHRM2CHRM4CHRM1CHRM3
SCHEMBL27312907 0.76 MTNR1A (0.41) MTNR1ACHRM2CHRM4CHRM1CHRM3
SCHEMBL27844281 0.75 MTNR1A (0.49) MTNR1ACHRM2CHRM4CHRM1CHRM3
SCHEMBL27570669 0.75 MTNR1A (0.40) MTNR1ACHRM2CHRM4CHRM1CHRM3
SCHEMBL27799208 0.74 MTNR1A (0.46) MTNR1ACHRM2CHRM4CHRM1CHRM3
SCHEMBL16222838 0.72 HTR2A (0.57) MTNR1ACHRM2CHRM4CHRM1CHRM3
SCHEMBL27478880 0.72 SRD5A1 (0.39) MTNR1ACHRM2CHRM4CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1906180-A New long acting beta-2-agonists and their use as medicaments BOEHRINGER INGELHEIM INT (DE) 2007-01-31 — — CN disclosed
Send feedback